Mirae Asset Capital Life Science

About

Mirae Asset Capital Life Science is focused on investing in life science. It was created as a joint venture between Mirae Asset Capital and Mirae Asset Global Investments. The group invests in companies working on drug development and clinical research. Its work includes supporting treatments for autoimmune diseases. The company reviews market data to guide its investment decisions. The portfolio includes organizations such as Accent Therapeutics.

Investment Focus

Stages

series-c

Sectors

fintech healthtech

Location

New York, US